Discovery of β-Carboline Derivatives as a Highly Potent Cardioprotectant against Myocardial Ischemia-Reperfusion Injury

Hong Zhang,Rong-Hong Zhang,Xiang-Ming Liao,Dan Yang,Yu-Chan Wang,Yong-Long Zhao,Guo-Bo Xu,Chun-Hua Liu,Yong-Jun Li,Shang-Gao Liao,Meng Zhou
DOI: https://doi.org/10.1021/acs.jmedchem.1c00384
IF: 8.039
2021-06-16
Journal of Medicinal Chemistry
Abstract:Timely myocardial reperfusion salvages ischemic myocardium from infarction, whereas reperfusion itself induces cardiomyocyte death, which is called myocardial ischemia/reperfusion (MI/R) injury. Herein, β-carboline derivative <b>17c</b> was designed and synthesized with obvious myocardial protective activity for the first time. Pretreatment of <b>17c</b> effectively protected the cardiomyocyte H9c2 cells from H<sub>2</sub>O<sub>2</sub>-induced lactate dehydrogenase leakage and restored the endogenous antioxidants, superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px). Besides, <b>17c</b> effectively protected the mitochondria through decreasing the reactive oxygen species overproduction and enhancing the mitochondrial membrane potential. As a result, <b>17c</b> significantly reduced the necrosis of cardiomyocytes in H<sub>2</sub>O<sub>2</sub>-induced oxidative stress, which was more potent than polydatin. In MI/R injury rats, <b>17c</b> pretreatment obviously increased the levels of SOD and GSH-Px and inhibited the apoptosis of cardiomyocytes. Through this way, the size of myocardial infarction was significantly reduced after MI/R injury <i>in vivo</i>, better than that of polydatin, suggesting that <b>17c</b> is a promising cardioprotectant for the prevention of MI/R injury.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00384?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00384</a>.Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00384/suppl_file/jm1c00384_si_001.csv">CSV</a>)Cytotoxicity of β-carboline derivatives; X-ray crystal structure of <b>14</b>; toxicity of H<sub>2</sub>O<sub>2</sub> against H9c2 cells; cell morphology of H9c2 cells pretreatment with <b>17c</b>; toxicity of <b>17c</b><i>in vivo</i>; representative ECG traces; and <sup>1</sup>H and <sup>13</sup>C NMR spectral data for compounds <b>10a–18b</b>, <b>21</b>, and <b>22a–24d</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00384/suppl_file/jm1c00384_si_002.pdf">PDF</a>)This article has not yet been cited by other publications.
chemistry, medicinal
What problem does this paper attempt to address?